Amdocs Net Worth
Amdocs Net Worth Breakdown | DOX |
Amdocs Net Worth Analysis
Amdocs' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Amdocs' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Amdocs' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Amdocs' net worth analysis. One common approach is to calculate Amdocs' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Amdocs' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Amdocs' net worth. This approach calculates the present value of Amdocs' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Amdocs' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Amdocs' net worth. This involves comparing Amdocs' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Amdocs' net worth relative to its peers.
Enterprise Value |
|
To determine if Amdocs is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Amdocs' net worth research are outlined below:
Latest headline from thelincolnianonline.com: Advisor OS LLC Raises Stock Holdings in Amdocs Limited |
Amdocs Quarterly Good Will |
|
Amdocs uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Amdocs. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Amdocs' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024 Upcoming Quarterly Report | View | |
8th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
5th of November 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
30th of September 2023 Last Financial Announcement | View |
Know Amdocs' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Amdocs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amdocs backward and forwards among themselves. Amdocs' institutional investor refers to the entity that pools money to purchase Amdocs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | American Century Companies Inc | 2025-03-31 | 2.2 M | Dimensional Fund Advisors, Inc. | 2025-03-31 | 2.1 M | Alliancebernstein L.p. | 2025-03-31 | 1.9 M | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 1.9 M | Geode Capital Management, Llc | 2025-03-31 | 1.8 M | Nordea Investment Mgmt Bank Demark A/s | 2025-03-31 | 1.6 M | State Street Corp | 2025-03-31 | 1.4 M | Bank Of America Corp | 2025-03-31 | 1.2 M | Neuberger Berman Group Llc | 2025-03-31 | 1 M | Fmr Inc | 2025-03-31 | 16.6 M | Hhg Plc | 2025-03-31 | 6.7 M |
Follow Amdocs' market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 9.83 B.Market Cap |
|
Project Amdocs' profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.13 | 0.10 | |
Return On Capital Employed | 0.15 | 0.14 | |
Return On Assets | 0.07 | 0.06 | |
Return On Equity | 0.13 | 0.07 |
When accessing Amdocs' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Amdocs' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Amdocs' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Amdocs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amdocs. Check Amdocs' Beneish M Score to see the likelihood of Amdocs' management manipulating its earnings.
Evaluate Amdocs' management efficiency
Amdocs has Return on Asset of 0.0783 % which means that on every $100 spent on assets, it made $0.0783 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1535 %, implying that it generated $0.1535 on every 100 dollars invested. Amdocs' management efficiency ratios could be used to measure how well Amdocs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.10 in 2025. Return On Capital Employed is likely to drop to 0.14 in 2025. At this time, Amdocs' Non Currrent Assets Other are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 676.1 M in 2025, whereas Total Assets are likely to drop slightly above 4.6 B in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 27.80 | 29.19 | |
Tangible Book Value Per Share | 3.92 | 3.78 | |
Enterprise Value Over EBITDA | 14.54 | 15.35 | |
Price Book Value Ratio | 2.58 | 1.42 | |
Enterprise Value Multiple | 14.54 | 15.35 | |
Price Fair Value | 2.58 | 1.42 | |
Enterprise Value | 7.9 B | 6.6 B |
The management team at Amdocs has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Enterprise Value Revenue 2.1972 | Revenue | Quarterly Revenue Growth (0.09) | Revenue Per Share | Return On Equity |
Amdocs Corporate Filings
6K | 19th of May 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
14th of May 2025 Other Reports | ViewVerify | |
17th of December 2024 Other Reports | ViewVerify | |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Amdocs Earnings per Share Projection vs Actual
Amdocs Corporate Management
Darcy Antonellis | Head Media | Profile | |
Oren Marmur | Head Network | Profile | |
Gary Miles | Chief Officer | Profile | |
Matthew Smith | Corporate Secretary | Profile | |
Mustafa Oyumi | Head Strategy | Profile |
Additional Tools for Amdocs Stock Analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.